Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia for Postoperative Sleep Promotion in Patients at High-risk of Obstructive Sleep Apnea
NCT06566482Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in sleep disorder, sponsored by Peking University First Hospital. Started Sep 2024; status: completed.
02
Drugs
dexmedetomidineesketamine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT06566482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06566482.